NIH-funded research NIH-funded research

Using systems biology to understand severe community-acquired pneumonia

Official title: Systems Biology Modeling of Severe Community-Acquired Pneumonia

Funded at Northwestern University · NIH-11248062 · Data updated 2026-11-12

This project analyzes patients' lung and blood samples with advanced lab tests and computer models to find biological patterns that can help guide treatment for people with severe pneumonia, including COVID-related cases.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionNorthwestern University
NIH-funded
Lab location1 site (Chicago, United States)
Project startJanuary 17, 2018
Project endDecember 31, 2027
Funding year2026
Award (this year)$393,834
NIH project number5U19AI135964-09
Project IDNIH-11248062 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adults hospitalized with severe community-acquired pneumonia or COVID-associated pneumonia, especially those in intensive care or on mechanical ventilation.

Less likely to help

Patients with mild outpatient pneumonia, non-infectious lung conditions, or children may not directly benefit from this adult ICU-focused research.

What this research studies

From the patient's perspective, researchers collect timed samples from the lungs and blood of people hospitalized with severe pneumonia, often requiring mechanical ventilation. They run multi-omics tests, including single-cell RNA sequencing, and analyze proteins and other biological markers from these samples. Then they apply machine learning and systems biology models to identify distinct clinical states and biological pathways linked to better or worse outcomes. The team will expand an existing dataset from the SCRIPT center and use those insights to inform future treatments and clinical trials.

Why it matters

Potential benefit: If successful, this work could help doctors match patients to treatments earlier and reduce deaths and complications from severe pneumonia.

How similar studies have gone: The original SCRIPT work helped lead to a trial of Auxora that showed a 53% reduction in 30-day mortality, showing prior success with this systems biology approach.

Where this research is happening

  • Northwestern University
    Chicago, United States
    Active

Researchers

  • Principal investigator: Wunderink, Richard G — Northwestern University
  • Study coordinator: Wunderink, Richard G

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.